Noninvasive Brain Stimulation for Carpal Tunnel Syndrome
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have used carbamazepine in the past 6 months.
Research shows that transcranial direct current stimulation (tDCS) can help improve hand motor skills in stroke patients, suggesting it might also be beneficial for conditions like Carpal Tunnel Syndrome that affect hand function.
12345Transcranial Direct Current Stimulation (tDCS) is generally considered safe for humans, with no severe complications reported at intensities of 4 mA or less for up to 60 minutes per day. Studies show that the amount of electricity used is much lower than levels that could cause permanent brain changes, and adverse effects are usually mild and temporary.
678910This treatment is unique because it uses noninvasive brain stimulation techniques, which are different from traditional methods like surgery or acupuncture. Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) aim to modulate brain activity to alleviate symptoms, offering a novel approach compared to other treatments that focus directly on the wrist or nerve.
1112131415Eligibility Criteria
This trial is for adults aged 18-80 with Carpal Tunnel Syndrome causing chronic pain despite previous treatments. Participants must have had pain for at least 6 months, feel it on most days, and rate it at least a 3 out of 10. They can't join if they're pregnant, have used certain medications recently, suffer from major depression or neurological issues like stroke or epilepsy, have metal implants in the brain, or a history of substance abuse.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 20 minutes of active or sham transcranial direct current stimulation (tDCS) and transcranial ultrasound (TUS) for the treatment of pain in Carpal Tunnel Syndrome
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Transcranial Direct Current Stimulation (tDCS) is already approved in United States, European Union, Canada, Australia for the following indications:
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder